SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Li Jingmei) "

Sökning: WFRF:(Li Jingmei)

  • Resultat 1-10 av 26
  • [1]23Nästa
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Ho, Peh Joo, et al. (författare)
  • Comparison of self-reported and register-based hospital medical data on comorbidities in women
  • 2019
  • Ingår i: Scientific Reports. - Nature Publishing Group. - 2045-2322. ; 9:1
  • Tidskriftsartikel (refereegranskat)abstract
    • Breast cancer patients commonly present with comorbidities which are known to influence treatment decisions and survival. We aim to examine agreement between self-reported and register-based medical records (National Patient Register [NPR]). Ascertainment of nine conditions, using individually-linked data from 64,961 women enrolled in the Swedish KARolinska MAmmography Project for Risk Prediction of Breast Cancer (KARMA) study. Agreement was assessed using observed proportion of agreement (overall agreement), expected proportion of agreement, and Cohen's Kappa statistic. Two-stage logistic regression models taking into account chance agreement were used to identify potential predictors of overall agreement. High levels of overall agreement (i.e. ≥86.6%) were observed for all conditions. Substantial agreement (Cohen's Kappa) was observed for myocardial infarction (0.74), diabetes (0.71) and stroke (0.64) between self-reported and NPR data. Moderate agreement was observed for preeclampsia (0.51) and hypertension (0.46). Fair agreement was observed for heart failure (0.40) and polycystic ovaries or ovarian cysts (0.27). For hyperlipidemia (0.14) and angina (0.10), slight agreement was observed. In most subgroups we observed negative specific agreement of >90%. There is no clear reference data source for ascertainment of conditions. Negative specific agreement between NPR and self-reported data is consistently high across all conditions.
2.
  • Lawrenson, Kate, et al. (författare)
  • Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
  • 2016
  • Ingår i: Nature Communications. - Nature Publishing Group. - 2041-1723. ; 7
  • Tidskriftsartikel (refereegranskat)abstract
    • A locus at 19p13 is associated with breast cancer (BC) and ovarian cancer (OC) risk. Here we analyse 438 SNPs in this region in 46,451 BC and 15,438 OC cases, 15,252 BRCA1 mutation carriers and 73,444 controls and identify 13 candidate causal SNPs associated with serous OC (P=9.2 × 10-20), ER-negative BC (P=1.1 × 10-13), BRCA1-associated BC (P=7.7 × 10-16) and triple negative BC (P-diff=2 × 10-5). Genotype-gene expression associations are identified for candidate target genes ANKLE1 (P=2 × 10-3) and ABHD8 (P<2 × 10-3). Chromosome conformation capture identifies interactions between four candidate SNPs and ABHD8, and luciferase assays indicate six risk alleles increased transactivation of the ADHD8 promoter. Targeted deletion of a region containing risk SNP rs56069439 in a putative enhancer induces ANKLE1 downregulation; and mRNA stability assays indicate functional effects for an ANKLE1 3′-UTR SNP. Altogether, these data suggest that multiple SNPs at 19p13 regulate ABHD8 and perhaps ANKLE1 expression, and indicate common mechanisms underlying breast and ovarian cancer risk.
3.
  • Bojesen, Stig E., et al. (författare)
  • Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
  • 2013
  • Ingår i: Nature Genetics. - Nature Publishing Group. - 1546-1718. ; 45:4, s. 371-384
  • Tidskriftsartikel (refereegranskat)abstract
    • TERT-locus SNPs and leukocyte telomere measures are reportedly associated with risks of multiple cancers. Using the Illumina custom genotyping array iCOG, we analyzed similar to 480 SNPs at the TERT locus in breast (n = 103,991), ovarian (n = 39,774) and BRCA1 mutation carrier (n = 11,705) cancer cases and controls. Leukocyte telomere measurements were also available for 53,724 participants. Most associations cluster into three independent peaks. The minor allele at the peak 1 SNP rs2736108 associates with longer telomeres (P = 5.8 x 10(-7)), lower risks for estrogen receptor (ER)-negative (P = 1.0 x 10(-8)) and BRCA1 mutation carrier (P = 1.1 x 10(-5)) breast cancers and altered promoter assay signal. The minor allele at the peak 2 SNP rs7705526 associates with longer telomeres (P = 2.3 x 10(-14)), higher risk of low-malignant-potential ovarian cancer (P = 1.3 x 10(-15)) and greater promoter activity. The minor alleles at the peak 3 SNPs rs10069690 and rs2242652 increase ER-negative (P = 1.2 x 10(-12)) and BRCA1 mutation carrier (P = 1.6 x 10-14) breast and invasive ovarian (P = 1.3 x 10(-11)) cancer risks but not via altered telomere length. The cancer risk alleles of rs2242652 and rs10069690, respectively, increase silencing and generate a truncated TERT splice variant.
  •  
4.
  • Hollestelle, Antoinette, et al. (författare)
  • No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
  • 2016
  • Ingår i: Gynecologic Oncology. - Academic Press. - 0090-8258. ; 141:2, s. 386-401
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective Clinical genetic testing is commercially available for rs61764370, an inherited variant residing in a KRAS 3′ UTR microRNA binding site, based on suggested associations with increased ovarian and breast cancer risk as well as with survival time. However, prior studies, emphasizing particular subgroups, were relatively small. Therefore, we comprehensively evaluated ovarian and breast cancer risks as well as clinical outcome associated with rs61764370. Methods Centralized genotyping and analysis were performed for 140,012 women enrolled in the Ovarian Cancer Association Consortium (15,357 ovarian cancer patients; 30,816 controls), the Breast Cancer Association Consortium (33,530 breast cancer patients; 37,640 controls), and the Consortium of Modifiers of BRCA1 and BRCA2 (14,765 BRCA1 and 7904 BRCA2 mutation carriers). Results We found no association with risk of ovarian cancer (OR = 0.99, 95% CI 0.94-1.04, p = 0.74) or breast cancer (OR = 0.98, 95% CI 0.94-1.01, p = 0.19) and results were consistent among mutation carriers (BRCA1, ovarian cancer HR = 1.09, 95% CI 0.97-1.23, p = 0.14, breast cancer HR = 1.04, 95% CI 0.97-1.12, p = 0.27; BRCA2, ovarian cancer HR = 0.89, 95% CI 0.71-1.13, p = 0.34, breast cancer HR = 1.06, 95% CI 0.94-1.19, p = 0.35). Null results were also obtained for associations with overall survival following ovarian cancer (HR = 0.94, 95% CI 0.83-1.07, p = 0.38), breast cancer (HR = 0.96, 95% CI 0.87-1.06, p = 0.38), and all other previously-reported associations. Conclusions rs61764370 is not associated with risk of ovarian or breast cancer nor with clinical outcome for patients with these cancers. Therefore, genotyping this variant has no clinical utility related to the prediction or management of these cancers.
  •  
5.
  • Hu, Han, et al. (författare)
  • Severe Traffic Crash Speaks Safety Facts From Mountain Roads in China
  • 2013
  • Ingår i: Proceedings of the 16th International Conference Road Safety on Four Continents : Beijing, China. 15-17 May 2013. - Linköping : Statens väg- och transportforskningsinstitut.
  • Konferensbidrag (övrigt vetenskapligt)abstract
    • objective to build up a systematic mountain road safety enhancement technology, this study analyses severe traffic crashes from 2006 to 2010 occurred on an inter-regional mountain arterial road network in south China. In order to digest these crash data collected from local traffic police stations, the authors conduct the in-depth crash analysis from the aspect of human, vehicle, road, and management. By developing the definition sets for crash deterministic causing factors judging system, the deterministic causes of severe accidents on mountain roads in China are deeply investigated. Results of our analysis indicate that human factor does weigh the most in the occurrence of the severe crashes; main crash types on mountain roads are running-off road, headon collision, overturned; Almost 76% severe crashes occurred on slope/curve combination sites; and freight car shall be given more attentions in reducing the severe accidents.
6.
  • Hu, Jingmei, et al. (författare)
  • Speed Control Effect Study on Optical Illusion Deceleration Markings
  • 2013
  • Ingår i: Proceedings of the 16th International Conference Road Safety on Four Continents : Beijing, China. 15-17 May 2013. - Linköping : Statens väg- och transportforskningsinstitut.
  • Konferensbidrag (övrigt vetenskapligt)abstract
    • The optical illusion deceleration marking is one of the commonly used speed control measures. In this research, the authors analyzed operating speed and trajectory of motor vehicle at intersection where optical illusion deceleration marking is installed. Quantitative and qualitative evaluation on effect of optical illusion deceleration marking is conducted. Results showed that optical illusion deceleration marking would help to reduce operating speed and average speed by 5-10km/h, to regulate motorcycle driver behavior, and to reduce speed difference, so that driving safety is ensured. Optical illusion deceleration marking is suitable for accident prone road sections on two-lane highways which main vehicle types are passenger car and motorcycle.
7.
  • Kar, Siddhartha P., et al. (författare)
  • The association between weight at birth and breast cancer risk revisited using Mendelian randomisation
  • 2019
  • Ingår i: European Journal of Epidemiology. - Springer. - 0393-2990. ; 34:6, s. 591-600
  • Tidskriftsartikel (refereegranskat)abstract
    • Observational studies suggest that higher birth weight (BW) is associated with increased risk of breast cancer in adult life. We conducted a two-sample Mendelian randomisation (MR) study to assess whether this association is causal. Sixty independent single nucleotide polymorphisms (SNPs) known to be associated at P < 5 × 10 −8 with BW were used to construct (1) a 41-SNP instrumental variable (IV) for univariable MR after removing SNPs with pleiotropic associations with other breast cancer risk factors and (2) a 49-SNP IV for multivariable MR after filtering SNPs for data availability. BW predicted by the 41-SNP IV was not associated with overall breast cancer risk in inverse-variance weighted (IVW) univariable MR analysis of genetic association data from 122,977 breast cancer cases and 105,974 controls (odds ratio = 0.86 per 500 g higher BW; 95% confidence interval 0.73–1.01). Sensitivity analyses using four alternative methods and three alternative IVs, including an IV with 59 of the 60 BW-associated SNPs, yielded similar results. Multivariable MR adjusting for the effects of the 49-SNP IV on birth length, adult height, adult body mass index, age at menarche, and age at menopause using IVW and MR-Egger methods provided estimates consistent with univariable analyses. Results were also similar when all analyses were repeated after restricting to estrogen receptor-positive or -negative breast cancer cases. Point estimates of the odds ratios from most analyses performed indicated an inverse relationship between genetically-predicted BW and breast cancer, but we are unable to rule out an association between the non-genetically-determined component of BW and breast cancer. Thus, genetically-predicted higher BW was not associated with an increased risk of breast cancer in adult life in our MR study.
8.
  • Li, Jinhai, et al. (författare)
  • Effects of Roadway Segment Alignments and Locations on Rural Two-Lane Highway Crash Rates
  • 2013
  • Ingår i: Proceedings of the 16th International Conference Road Safety on Four Continents : Beijing, China. 15-17 May 2013. - Linköping : Statens väg- och transportforskningsinstitut.
  • Konferensbidrag (övrigt vetenskapligt)abstract
    • This paper investigates the effects of road segment alignment and location on rural two-lane highway crash rates by taking the mileage of segment types into consideration. Roadway segments are classified and redefined according to the segment alignment and location. The definitions of crash rates in terms of segment alignment and location are presented respectively. The study gathers crash data and the roadway geometric information of rural two-lane highways in southwest of China and crash rates of each segment type are proposed by utilizing the proposed definitions. The result indicates that gentle-slope &amp; sharp-curve segments and intersections tend to have extremely higher crash rates than the other types of segments.
9.
  • Li, Jingmei (författare)
  • Genetic determinants of breast cancer risk
  • 2011
  • Doktorsavhandling (övrigt vetenskapligt)abstract
    • The main purpose of this thesis was to identify genetic risk factors using both hypothesis-based and hypothesis-free approaches. In an attempt to identify common disease susceptibility alleles for breast cancer, we started off with a hypothesis-free approach, and performed a combined analysis of three genome-wide association studies (GWAS), involving 2,702 women of European ancestry with invasive breast cancer and 5,726 controls. As GWAS has been said to underperform for studying complex diseases such as breast cancer, we investigated to see if the variance explained by common variants could be increased by studying specific disease subtypes. Breast cancer may be characterized on the basis of whether estrogen receptors (ER) are expressed in the tumour cells. The two breast cancer tumour subtypes (ER-positive and ERnegative) are generally considered as biologically distinct diseases and have been associated with remarkably different gene expression profiles. ER status is important clinically, and is used both as a prognosticator and treatment predictor since it determines if a patient may benefit from anti-estrogen therapy. We thus performed an independent GWAS using a subset of ER-negative breast cancer cases and all of the controls from the initial genome-wide study, and, in addition, also evaluated whether the two cancer subtypes are fundamentally different on a germline level. Besides hypothesis-free GWAS, we also conducted hypothesis-based analyses based on candidate pathways to identify common variants associated with breast cancer. Several studies have examined the effect of genetic variants in genes involved in the estrogen metabolic pathway on mammographic density, but the number of loci studied and the sample sizes evaluated have been small and pathways have not been evaluated comprehensively. We evaluated a total of 239 SNPs in 34 genes in the estrogen metabolic pathway in 1,731 Swedish women who participated in a breast cancer case-control study. Slightly venturing outside the genetic scope of this thesis, we looked at a breast cancer risk factor - body size - that is associated with very different postmenopausal breast cancer risks at different time points in a woman’s lifetime, namely, birth, childhood, and postmenopausal adult. The significance of these studies will be apparent when, using the new genetic and epidemiological knowledge found, we are able to classify women according to high or low risk of breast cancer on the basis of genetic disposition or other breast cancer risk factors, so that appropriate interventions and disease management decisions may be made, to ultimately reduce incidence and mortality of breast cancer.
10.
  • Li, Jingmei, et al. (författare)
  • Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort
  • 2019
  • Ingår i: International Journal of Cancer. - John Wiley & Sons. - 0020-7136. ; 144:5, s. 1195-1204
  • Tidskriftsartikel (refereegranskat)abstract
    • Breast cancer patients with BRCA1/2-driven tumors may benefit from targeted therapy. It is not clear whether current BRCA screening guidelines are effective at identifying these patients. The purpose of our study was to evaluate the prevalence of inherited BRCA1/2 pathogenic variants in a large, clinically representative breast cancer cohort and to estimate the proportion of BRCA1/2 carriers not detected by selectively screening individuals with the highest probability of being carriers according to current clinical guidelines. The study included 5,122 unselected Swedish breast cancer patients diagnosed from 2001 to 2008. Target sequence enrichment (48.48 Fluidigm Access Arrays) and sequencing were performed (Illumina Hi-Seq 2,500 instrument, v4 chemistry). Differences in patient and tumor characteristics of BRCA1/2 carriers who were already identified as part of clinical BRCA1/2 testing routines and additional BRCA1/2 carriers found by sequencing the entire study population were compared using logistic regression models. Ninety-two of 5,099 patients with valid variant calls were identified as BRCA1/2 carriers by screening all study participants (1.8%). Only 416 study participants (8.2%) were screened as part of clinical practice, but this identified 35 out of 92 carriers (38.0%). Clinically identified carriers were younger, less likely postmenopausal and more likely to be associated with familiar ovarian cancer compared to the additional carriers identified by screening all patients. More BRCA2 (34/42, 81.0%) than BRCA1 carriers (23/50, 46%) were missed by clinical screening. In conclusion, BRCA1/2 mutation prevalence in unselected breast cancer patients was 1.8%. Six in ten BRCA carriers were not detected by selective clinical screening of individuals.
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 26
  • [1]23Nästa
Åtkomst
fritt online (15)
Typ av publikation
tidskriftsartikel (22)
konferensbidrag (3)
doktorsavhandling (1)
Typ av innehåll
refereegranskat (19)
övrigt vetenskapligt (7)
Författare/redaktör
Li, Jingmei (22)
Czene, Kamila (19)
Hall, Per (18)
Chang-Claude, Jenny (12)
Giles, Graham G (12)
Brenner, Hermann (12)
visa fler...
Milne, Roger L. (12)
Margolin, Sara (12)
Andrulis, Irene L. (12)
Guenel, Pascal (12)
Radice, Paolo (12)
Humphreys, Keith (12)
Nevanlinna, Heli (11)
Blomqvist, Carl, (11)
Wang, Qin (11)
Haiman, Christopher ... (11)
Garcia-Closas, Monts ... (11)
Hopper, John L. (11)
Benitez, Javier (11)
Burwinkel, Barbara (11)
Brauch, Hiltrud (11)
Hamann, Ute (11)
Lindblom, Annika (11)
Cox, Angela (11)
Anton-Culver, Hoda (11)
Knight, Julia A. (11)
Bolla, Manjeet K. (11)
Bojesen, Stig E. (11)
Lubinski, Jan (11)
Jakubowska, Anna (11)
Peterlongo, Paolo (11)
Simard, Jacques (11)
Fasching, Peter A. (11)
Lambrechts, Diether (11)
Neuhausen, Susan L (10)
Eriksson, Mikael, (10)
Flyger, Henrik (10)
Devilee, Peter (10)
Meindl, Alfons (10)
Mannermaa, Arto (10)
Kosma, Veli-Matti (10)
Olson, Janet E. (10)
Dunning, Alison M. (10)
Rudolph, Anja (10)
Figueroa, Jonine (10)
Zheng, Wei (10)
Flesch-Janys, Dieter (10)
Winqvist, Robert (10)
Dumont, Martine (10)
Michailidou, Kyriaki (10)
visa färre...
Lärosäte
Karolinska Institutet (20)
Lunds universitet (12)
Uppsala universitet (5)
Örebro universitet (4)
VTI - Statens väg- och transportforskningsinstitut (3)
Umeå universitet (2)
visa fler...
Göteborgs universitet (1)
Kungliga Tekniska Högskolan (1)
Linköpings universitet (1)
visa färre...
Språk
Engelska (26)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (21)
Teknik (3)
Samhällsvetenskap (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy